Schuyler Hospital | |
220 Steuben Street, Montour Falls, New York 14865 | |
(607) 530-7121 | |
Not Available |
Name | Schuyler Hospital |
---|---|
Type | Critical Access Hospital |
Location | 220 Steuben Street, Montour Falls, New York |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 331313 |
NPI Number | 1093169732 |
Organization Name | SCHUYLER HOSPITAL |
Address | 220 Steuben St, Montour Falls, NY 14865 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 607-535-8639 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
BioAdvance, the University City Science Center and Wharton Small Business Development Center (SBDC) are collaborating to develop Career GPS, a program which is designed to help displaced biopharmaceutical professionals navigate the Greater Philadelphia region's entrepreneurial career eco-system.
Ahead of Wednesday's mark-up of the FY 2011 state and foreign ops appropriations bill, Foreign Policy's "The Cable" blog examines recent comments made by House Foreign Operations Subcommittee Chairwoman Nita Lowey (D-N.Y.) in which she "promised … to remove all the Afghanistan foreign operations and aid money from next year's funding unless she can be assured none of the funds are being wasted due to corruption in the Afghanistan government."
› Verified 1 days ago
NPI Number | 1639150477 |
Organization Name | SCHUYLER HOSPITAL INC |
Address | 220 Steuben St, Montour Falls, NY 14865 |
Hospital Type | General Acute Care Hospital |
Phone Number | 607-535-7121 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
BioAdvance, the University City Science Center and Wharton Small Business Development Center (SBDC) are collaborating to develop Career GPS, a program which is designed to help displaced biopharmaceutical professionals navigate the Greater Philadelphia region's entrepreneurial career eco-system.
Ahead of Wednesday's mark-up of the FY 2011 state and foreign ops appropriations bill, Foreign Policy's "The Cable" blog examines recent comments made by House Foreign Operations Subcommittee Chairwoman Nita Lowey (D-N.Y.) in which she "promised … to remove all the Afghanistan foreign operations and aid money from next year's funding unless she can be assured none of the funds are being wasted due to corruption in the Afghanistan government."
› Verified 1 days ago
Able to receive lab results electronically | Not Available |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
BioAdvance, the University City Science Center and Wharton Small Business Development Center (SBDC) are collaborating to develop Career GPS, a program which is designed to help displaced biopharmaceutical professionals navigate the Greater Philadelphia region's entrepreneurial career eco-system.
Ahead of Wednesday's mark-up of the FY 2011 state and foreign ops appropriations bill, Foreign Policy's "The Cable" blog examines recent comments made by House Foreign Operations Subcommittee Chairwoman Nita Lowey (D-N.Y.) in which she "promised … to remove all the Afghanistan foreign operations and aid money from next year's funding unless she can be assured none of the funds are being wasted due to corruption in the Afghanistan government."
› Verified 1 days ago
Schuyler Hospital Critical Access Hospital Location: 220 Steuben Street, Montour Falls, New York 14865 Phone: (607) 530-7121 |